|Table of Contents|

Research progress on the effect of neck radiotherapy on thyroid function in head and neck tumors

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 14
Page:
2719-2722
Research Field:
Publishing date:

Info

Title:
Research progress on the effect of neck radiotherapy on thyroid function in head and neck tumors
Author(s):
ZHAO Lihong; HAO Chuncheng
Heilongjiang Cancer Hospital,Heilongjiang Harbin 150000,China.
Keywords:
head and neck tumors; radiotherapy; hypothyroidism
PACS:
R730.5
DOI:
10.3969/j.issn.1672-4992.2023.14.029
Abstract:
After radiotherapy for head and neck tumors,it will cause hypothyroidism(HT),and the incidence rate in 5 years is between 20% to 60%.This paper reviews the relationship between RIHT and radiation dose-volume parameters,age,radiation technology,gender and generative mechanism.There are many studies,but the conclusions are different,then the dose-volume threshold cannot be defined clearly.The consensus is that higher thyroid dose and smaller thyroid volume will increase the incidence of RIHT,the age,radiation technology and gender will have an impact on RIHT.A large number of prospective large samples are needed for further research to develop more normal tissue complication probability(NTCP) models and explore the relationship between hypothalamic-pituitary axis and RIHT.

References:

［1］REINERS C,DROZD V,YAMASHITA S.Hypothyroidism after radiation exposure:brief narrative review［J］.Journal of Neural Transmission,2020,127(11):1455-1466.
［2］VOGELIUS IR,BENTZEN SM,MARALDO MV,et al.Risk factors for radiation-induced hypothyroidism:a literature-based meta-analysis［J］.Cancer,2011,117(23):5250-5260.
［3］DARVISH L,GHORBANI M,TESHNIZI SH,et al.Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy:a systematic review and Meta-analysis［J］.Clin Transl Oncol,2018,20(11):1430-1438.
［4］MCDOWELL LJ,ROCK K,XU W,et al.Long-term late toxicity,quality of life,and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy［J］.International Journal of Radiation Oncology?Biology?Physics,2018,102(2):340-352.
［5］CHOW JCH,CHEUNG KM,CHEUNG GTC,et al.Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer:A systematic review［J］.Clin Transl Radiat Oncol,2022,33:83-92.
［6］BHANDARE N,KENNEDY L,MALYAPA RS,et al.Primary and central hypothyroidism after radiotherapy for head-and-neck tumors［J］.International Journal of Radiation Oncology Biology Physics,2007,68(4):1131-1139.
［7］INOUE E,OKAJIMA K,DOI H,et al.Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer［J］.Acta Otolaryngol,2021,141(11):1022-1026.
［8］TAMURA K,SHIMAOKA K,FRIEDMAN M.Thyroid abnormalities associated with treatment of malignant lymphoma［J］.Cancer,1981,47(11):2704-2711.
［9］Aodenggaowa.Analysis of risk factors for thyroid injury after radiotherapy for head and neck tumors［J］.World Latest Medicine Information,2019,19(77):23-24.
［10］WOLNY-ROKICKA E,TUKIENDORF A,WYDMANSKI J,et al.Thyroid function after postoperative radiation therapy in patients with breast cancer［J］.Asian Pac J Cancer Prev,2016,17(10):4577-4581.
［11］ANSARI L,NASIRI N,AMINOLROAYAEI F,et al.The measurement of thyroid absorbed dose by gafchromic? EBT2 film and changes in thyroid hormone levels following radiotherapy in patients with breast cancer［J］.Journal of Medical Signals and Sensors,2020,10(1):42-47.
［12］WU YH,WANG HM,CHEN HH,et al.Hypothyroidism after radiotherapy for nasopharyngeal cancer patients［J］.Int J Radiat Oncol Biol Phys,2010,76(4):1133-1139.
［13］ALTERIO D,JERECZEKFOSSA BA,FRABCHI B,et al.Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer:A retrosPective analysis of seventy-three patients［J］.International Journal of Radiation Oncology Biology Physics,2007,67(1):144-150.
［14］SOMMAT K,ONG WS,HUSSAIN A,et al.Thyroid V40 predicts primary hypothyroidism after intensity modulated radiation therapy for nasopharyngeal carcinoma［J］.International Journal of Radiation Oncology Biology Physics,2017,98(3):574-580.
［15］MURTHY V,NARANG K,GHOSH-LASKAR S,et al.Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers:Prospective data from 2 randomized controlled trials［J］.Head Neck,2014,36(11):1573-1580.
［16］CUI YY,QIAN LT,XUE XD.Analysis of the protective effect of volume intensity modulated radiotherapy and conformal intensity modulated radiotherapy for newly treated nasopharyngeal carcinoma on thyroid gland［J］.Journal of Anhui Medical University，2016,51(10)：1499-1503.
［17］ZHANG LY,TANG HT,LI SR,et al.Effect of volume rotating intensity modulated radiotherapy on thyroid hemodynamics and function in patients with newly diagnosed nasopharyngeal carcinoma［J］. Chinese Journal of Surgical Oncology，2019,11(4)：283-287.
［18］PLAAT RE,VAN DIJK BAC,MULLER KOBOLD AC,et al.Onset of hypothyroidism after total laryngectomy:Effects of thyroid gland surgery and preoperative and postoperative radiotherapy［J］.Head Neck,2020,42(4)：636-644.
［19］DIAZ R,JABOIN JJ,MORALES-PALIZA M,et al.Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer［J］.Int J Radiat Oncol Biol Phys,2010,77(2)：468-476.
［20］KANYILMAZ G,AKTAN M,KOC M,et al.Radiation-induced hypothyroidism in patients with breast cancer:a retrospective analysis of 243 cases［J］.Med Dosim,2017,42(3)：190-196.
［21］KUTEN A,LUBOCHITSKI R,FISHMAN G,et al.Postradiotherapy hypothyroidism:radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy［J］.J Surg Oncol,1996,61(4):281-288.
［22］HUANG CL,TAN HW,GUO R,et al.Thyroid dose-volume thresholds for the risk ofradiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A-single-institution study［J］.Cancer Medicine,2019,8(16):6887-6893.
［23］AKGUN Z,ATASOY BM,OZEN Z,et al.V30 as a predictor for radiation-induced hypothyroidism:a dosimetric analysis in patients who received radiotherapy to the neck［J］.Radiation Oncology,2014,9(1):104-110.
［24］EL-SHEBINEY M,EL-MASHAD N,EL-MASHAD W,et al.Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer［J］.Journal of the Egyptian National Cancer Institute,2018,30(1):33-38.
［25］PENG L,MAO YP,HUANG CL,et al.A new model for predicting hypothyroidism after intensity-modulated radiotherapy for nasopharyngeal carcinoma［J］.Front Oncol,2020,10:551255.
［26］PRPIC M,KRULJAC I,KUST D,et al.Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients［J］.Radiol Oncol,2019,53(4):488-496.
［27］LIN AJ,ZHANG J,CHO-LIM J,et al.Postradiation hypothyroidism in head and neck cancers:A department of veterans affairs single-institution case-control dosimetry study［J］.Med Dosim,2019,44(1):56-60.
［28］SACHDEV S,REFAAT T,BACCHUS ID,et al.Thyroid V50 highly predictive of hypothyroidism in head-and-neck cancer patients treated with intensity-modulated radiotherapy (IMRT)［J］.American Journal of Clinical Oncology Cancer Clinical Trials,2017,40(4):413-417.
［29］ZHOU L,CHEN J,SHEN W,et al.Thyroid V50 is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy:a retrospective study［J］.Radiation Oncology(London,England),2020,15(1):68-74.
［30］HACIISLAMOGLU E,CANYILMAZ E,GEDIK S,et al.Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients［J］.Journal of Applied Clinical Medical Physics,2019,20(7):135-141.
［31］ULGER S,ULGER Z,YILDIZ F,et al.Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma［J］.Med Oncol,2007,24(1):91-94.
［32］RONJOM MF,BRINK C,BENTZEN SM,et al.External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort［J］.Acta Oncologica,2015,54(9):1301-1309.
［33］BOOMSMA MJ,BIJI HP,CHRISTIANEN ME,et al.A prospective cohort study on radiation-induced Hypothyroidism:Development of an NTCP model［J］.Int J Radiat Oncol Biol Phys,2012,84(3):351-356.
［34］NOWICKA Z,TOMASIK B,PAPIS-UBYCH A,et al.Radiation-induced hypothyroidism in patients with oropharyngeal cancer treated with IMRT:Independent and external validation of five normal tissue complication probability models［J］.Cancers(Basel),2020,12(9):284-290.
［35］CELLA L,LIUZZZ R,CONSON M,et al.Development of multivariate NTCP models for radiation-induced hypothyroidism:a comparative analysis［J］.Radiat Oncol,2012,12(7):224-230.
［36］KYRIAKAKIS N,LYNCH J,ORME SM,et al.Hypothalamic-pituitary axis irradiation dose thresholds for the development of hypopituitarism in adult-onset gliomas［J］.Clin Endocrinol(Oxf),2019,91(1):131-140.
［37］MASSIMINO M,PODDA M,GANDOLA L,et al.Long-term results of suppressing thyroid-stimulating hormone during radiotherapy to prevent primary hypothyroidism in medulloblastoma/PNET and Hodgkin lymphoma:a prospective cohort study［J］.Frontiers of Medicine,2020,56(4):1-7.

Memo

Memo:
-
Last Update: 1900-01-01